Publication:
Efficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study

Simple item page
dc.contributor.authorsHatemi, G.; Mahr, A.; Takeno, M.; Kim, D.; Saadoun, D.; Direskeneli, H.; Cheng, S.; McCue, S.; Paris, M.; Chen, M.; Yazici, Y.
dc.date.accessioned2022-03-10T18:00:01Z
dc.date.accessioned2026-01-10T18:38:49Z
dc.date.available2022-03-10T18:00:01Z
dc.date.issued2019
dc.identifier.doidoiWOS:000531104800037
dc.identifier.eissn1424-3997
dc.identifier.issn1424-7860
dc.identifier.urihttps://hdl.handle.net/11424/222256
dc.identifier.wosWOS:000531104800037
dc.language.isoeng
dc.publisherE M H SWISS MEDICAL PUBLISHERS LTD
dc.relation.ispartofSWISS MEDICAL WEEKLY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEfficacy of apremilast for oral ulcers associated with active Behcet's syndrome over 64 weeks: results from a phase III study
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPage16S
oaire.citation.startPage16S
oaire.citation.titleSWISS MEDICAL WEEKLY

Files

Collections

Araştırma Çıktıları